Medpace

Medpace

Yahoo Finance • 19 hours ago

Medpace (MEDP): Buy, Sell, or Hold Post Q2 Earnings?

Medpace (MEDP): Buy, Sell, or Hold Post Q2 Earnings? Medpace currently trades at $610.21 and has been a dream stock for shareholders. It's returned 238% since August 2021, more than tripling the S&P 500's 70.1% gain. The company has also... Full story

Yahoo Finance • 2 days ago

CON vs. MEDP: Which Stock Should Value Investors Buy Now?

Investors with an interest in Medical Services stocks have likely encountered both Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer... Full story

Yahoo Finance • 2 days ago

What Investors Should Know About Medpace CEO Troendle Selling $10 Million in Stock

August J. Troendle, President & CEO of Medpace Holdings, Inc. (NASDAQ:MEDP), sold 15,978 shares of common stock in a transaction valued at $10.0 million. SEC Form 4 filing Transaction summary Metric Value Transaction value $10.0 million... Full story

Yahoo Finance • 13 days ago

2 Mid-Cap Stocks Worth Your Attention and 1 We Question

2 Mid-Cap Stocks Worth Your Attention and 1 We Question Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corpora... Full story

Yahoo Finance • 23 days ago

ZBH's Q2 Earnings Beat, '26 View Raised, Stock Up in Pre-Market

Zimmer Biomet Holdings, Inc. ZBH posted second-quarter 2026 adjusted earnings per share of $2.07, which beat the Zacks Consensus Estimate of $2.01 by 2.99%. The adjusted figure was unchanged year over year. The quarter's adjustments inclu... Full story

Yahoo Finance • 28 days ago

3 Cash-Heavy Stocks on Our Watchlist

3 Cash-Heavy Stocks on Our Watchlist Companies with more cash than debt often have stronger financial flexibility, making them attractive in uncertain markets. With interest payments less of a worry, these businesses can invest more in gr... Full story

Yahoo Finance • last month

Medpace Holdings Inc (MEDP) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Record ...

This article first appeared on GuruFocus. Revenue: $707.3 million in Q2 2026, a 17.2% year-over-year increase. Year-to-Date Revenue: $1.41 billion, up 21.7%. EBITDA: $153.4 million in Q2 2026, a 17.6% increase from Q2 2025. EBITDA Margin:... Full story

Yahoo Finance • last month

Stock Indexes Mixed Ahead of Alphabet’s Earnings

The S&P 500 Index ($SPX) (SPY) today is down -0.09%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.10%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.29%.  September E-mini S&P futures (ESU26) are down -0.07%, and September E... Full story

Yahoo Finance • last month

Stock Indexes Retreat as Crude Oil and Bond Yields Climb

The S&P 500 Index ($SPX) (SPY) today is down -0.13%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.15%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.48%.  September E-mini S&P futures (ESU26) are down -0.10%, and September E... Full story

Yahoo Finance • last month

Medpace To Report Q2 Results; Can Growth Sustain After A Strong Start To 2026?

(RTTNews) - Medpace Holdings, Inc. (MEDP) will report second-quarter 2026 results on July 22, 2026, with investors watching whether the contract research organization can extend the robust growth it delivered in Q1 and maintain its elevate... Full story

Yahoo Finance • 2 months ago

2 Healthcare Stocks to Consider Right Now and 1 We Brush Off

2 Healthcare Stocks to Consider Right Now and 1 We Brush Off From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited f... Full story

Yahoo Finance • 2 months ago

Medpace (MEDP) Stock Weighing Modest Undervaluation Against Rich P/E And Mixed Momentum

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Medpace Holdings (MEDP) has drawn investor attention after recent share price moves, with the stock roughly flat over the p... Full story

Yahoo Finance • 3 months ago

Charles River Labs (CRL) Pulled Back Due to AI Disruption Fears

Madison Small Cap Fund, managed by Madison Funds, released its Q1 2026 investor letter. A copy of the letter is available to download here. The Madison Small Cap Fund (class I) increased by 0.10% in the first quarter, trailing behind the R... Full story

Yahoo Finance • 3 months ago

Madison Small Cap Fund Increased Medpace Holdings (MEDP), Downplaying AI Fears

Madison Small Cap Fund, managed by Madison Funds, released its Q1 2026 investor letter. A copy of the letter is available to download here. The Madison Small Cap Fund (class I) increased by 0.10% in the first quarter, trailing behind the R... Full story

Yahoo Finance • 3 months ago

Safirstein Law LLC Announces That A Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP)

RIDGEWOOD, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- RIDGEWOOD, N.J., June 8, 2026 (GLOBE NEWSWIRE) -- Safirstein Law LLC announces that a class action lawsuit has been filed on behalf of shareholders against Medpace Holdings, Inc. ("Medpa... Full story

Yahoo Finance • 3 months ago

MEDP DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important June 8 Deadline in Securities Class Action - MEDP

NEW YORK, June 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the... Full story

Yahoo Finance • 3 months ago

How Investors May Respond To Medpace (MEDP) Lawsuits And EVP Shift In Operating Leadership

In early June 2026, Medpace Holdings appointed long-time insider Brad W. Hansman as Executive Vice President, Operations, sharing principal operating officer responsibilities with Susan E. Burwig. At the same time, Medpace is confronting m... Full story

Yahoo Finance • 3 months ago

Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (NASDAQ: MEDP) and cert... Full story

Yahoo Finance • 3 months ago

MEDPACE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class Action - MEDP

NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the... Full story

Yahoo Finance • 3 months ago

3 Cash-Producing Stocks with Promising Prospects

Businesses with strong free cash flow tend to be more adaptable and resilient. Some of these companies shine bright by using their cash wisely to strengthen their market positions. Not all companies are created equal, and StockStory is he... Full story